Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
January 24, 2013
from PR Newswire
Watson Confirms Opana® ER Patent Challenge
January 23, 2013
from PR Newswire
Perfect Trade Setups, How to Play ACRX, ENMD, NLY and WPI
January 23, 2013
Watson Acquires Uteron Pharma SA
January 23, 2013
from PR Newswire
Today's Research on Mylan and Watson Pharmaceuticals: One Drug Maker's Sorrow is Another One's Joy
January 18, 2013
from PR Newswire
The Reason It Trades, What's Moving CELG, LULU, PRAA and WPI
January 16, 2013
The Real Story Behind AEGR, GNMK, ENOC and WPI
January 14, 2013
Watson To Host 2013 Investor Meeting January 25 In New York
January 11, 2013
from PR Newswire
Key to Success, How to Profit: IT, WPI, LAD and GOOG
January 04, 2013
Watson's Generic Lysteda® Receives FDA Approval
January 03, 2013
from PR Newswire
Watson Confirms Velcade® Patent Challenge
December 28, 2012
from PR Newswire
EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals
December 28, 2012
from PR Newswire
LYB, WPI, SSYS and HW Freshly Hit a New 52-Week High
December 26, 2012
Watson to Present at the 31st Annual J.P. Morgan Healthcare Conference
December 21, 2012
from PR Newswire
Watson to Present at 2013 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
December 20, 2012
from PR Newswire
Watson to Present at the 2012 Piper Jaffray Health Care Conference
November 14, 2012
from PR Newswire
Watson's Generic Revatio® Receives FDA Approval
November 12, 2012
from PR Newswire
Columbia Laboratories Reports Third Quarter 2012 Financial Results
November 08, 2012
Watson to Present at the Jefferies 2012 Global Healthcare Conference
November 06, 2012
from PR Newswire
Watson to Present at the 2012 Annual Credit Suisse Healthcare Conference
November 06, 2012
from PR Newswire
Watson Third Quarter 2012 Non-GAAP Diluted EPS Increases 24% to $1.35; Net Revenue Increases 19% to $1.29 Billion
November 01, 2012
from PR Newswire
Watson Announces Global Generics Management Team
October 31, 2012
from PR Newswire
Watson Announces New Name -- Actavis -- for Global Operations
October 31, 2012
from PR Newswire
Watson Completes Actavis Acquisition
October 31, 2012
from PR Newswire
Watson Announces Sale of Rugby OTC Product Trademark and Assets to Major Pharmaceuticals, a division of The Harvard Drug Group, LLC
October 29, 2012
from PR Newswire
Watson Receives FDA Approval for Generic Actos®
October 26, 2012
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here